The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiac Rhythm Management (CRM) Market Research Report 2025
Synopsis
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
The global Cardiac Rhythm Management (CRM) market was valued at US$ 12120 million in 2023 and is anticipated to reach US$ 15290 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
North America is the largest Cardiac Rhythm Management (CRM) Devices market with about 87% market share. Europe is follower, accounting for about 11% market share.The key manufacturers are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 88% market share.
This report aims to provide a comprehensive presentation of the global market for Cardiac Rhythm Management (CRM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Rhythm Management (CRM).
Report Scope
The Cardiac Rhythm Management (CRM) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Rhythm Management (CRM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Rhythm Management (CRM) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova
Physio-Control
Schiller
Medtronic
Abbott
Boston Scientific
Koninklijke Philips
Zoll Medical
Biotronik
Segment by Type
Pacemaker
Defibrillator
Cardiac Resynchronization Therapy
Segment by Application
Hospitals
Home Health Care
Ambulatory Services
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Rhythm Management (CRM) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
The global Cardiac Rhythm Management (CRM) market was valued at US$ 12120 million in 2023 and is anticipated to reach US$ 15290 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
North America is the largest Cardiac Rhythm Management (CRM) Devices market with about 87% market share. Europe is follower, accounting for about 11% market share.The key manufacturers are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 88% market share.
This report aims to provide a comprehensive presentation of the global market for Cardiac Rhythm Management (CRM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Rhythm Management (CRM).
Report Scope
The Cardiac Rhythm Management (CRM) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Rhythm Management (CRM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Rhythm Management (CRM) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova
Physio-Control
Schiller
Medtronic
Abbott
Boston Scientific
Koninklijke Philips
Zoll Medical
Biotronik
Segment by Type
Pacemaker
Defibrillator
Cardiac Resynchronization Therapy
Segment by Application
Hospitals
Home Health Care
Ambulatory Services
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Rhythm Management (CRM) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Rhythm Management (CRM) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pacemaker
1.2.3 Defibrillator
1.2.4 Cardiac Resynchronization Therapy
1.3 Market by Application
1.3.1 Global Cardiac Rhythm Management (CRM) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Home Health Care
1.3.4 Ambulatory Services
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Rhythm Management (CRM) Market Perspective (2019-2030)
2.2 Cardiac Rhythm Management (CRM) Growth Trends by Region
2.2.1 Global Cardiac Rhythm Management (CRM) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cardiac Rhythm Management (CRM) Historic Market Size by Region (2019-2024)
2.2.3 Cardiac Rhythm Management (CRM) Forecasted Market Size by Region (2025-2030)
2.3 Cardiac Rhythm Management (CRM) Market Dynamics
2.3.1 Cardiac Rhythm Management (CRM) Industry Trends
2.3.2 Cardiac Rhythm Management (CRM) Market Drivers
2.3.3 Cardiac Rhythm Management (CRM) Market Challenges
2.3.4 Cardiac Rhythm Management (CRM) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Rhythm Management (CRM) Players by Revenue
3.1.1 Global Top Cardiac Rhythm Management (CRM) Players by Revenue (2019-2024)
3.1.2 Global Cardiac Rhythm Management (CRM) Revenue Market Share by Players (2019-2024)
3.2 Global Cardiac Rhythm Management (CRM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Rhythm Management (CRM) Revenue
3.4 Global Cardiac Rhythm Management (CRM) Market Concentration Ratio
3.4.1 Global Cardiac Rhythm Management (CRM) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Rhythm Management (CRM) Revenue in 2023
3.5 Cardiac Rhythm Management (CRM) Key Players Head office and Area Served
3.6 Key Players Cardiac Rhythm Management (CRM) Product Solution and Service
3.7 Date of Enter into Cardiac Rhythm Management (CRM) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Rhythm Management (CRM) Breakdown Data by Type
4.1 Global Cardiac Rhythm Management (CRM) Historic Market Size by Type (2019-2024)
4.2 Global Cardiac Rhythm Management (CRM) Forecasted Market Size by Type (2025-2030)
5 Cardiac Rhythm Management (CRM) Breakdown Data by Application
5.1 Global Cardiac Rhythm Management (CRM) Historic Market Size by Application (2019-2024)
5.2 Global Cardiac Rhythm Management (CRM) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cardiac Rhythm Management (CRM) Market Size (2019-2030)
6.2 North America Cardiac Rhythm Management (CRM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cardiac Rhythm Management (CRM) Market Size by Country (2019-2024)
6.4 North America Cardiac Rhythm Management (CRM) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Rhythm Management (CRM) Market Size (2019-2030)
7.2 Europe Cardiac Rhythm Management (CRM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cardiac Rhythm Management (CRM) Market Size by Country (2019-2024)
7.4 Europe Cardiac Rhythm Management (CRM) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Rhythm Management (CRM) Market Size (2019-2030)
8.2 Asia-Pacific Cardiac Rhythm Management (CRM) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cardiac Rhythm Management (CRM) Market Size by Region (2019-2024)
8.4 Asia-Pacific Cardiac Rhythm Management (CRM) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Rhythm Management (CRM) Market Size (2019-2030)
9.2 Latin America Cardiac Rhythm Management (CRM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cardiac Rhythm Management (CRM) Market Size by Country (2019-2024)
9.4 Latin America Cardiac Rhythm Management (CRM) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Rhythm Management (CRM) Market Size (2019-2030)
10.2 Middle East & Africa Cardiac Rhythm Management (CRM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cardiac Rhythm Management (CRM) Market Size by Country (2019-2024)
10.4 Middle East & Africa Cardiac Rhythm Management (CRM) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LivaNova
11.1.1 LivaNova Company Detail
11.1.2 LivaNova Business Overview
11.1.3 LivaNova Cardiac Rhythm Management (CRM) Introduction
11.1.4 LivaNova Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.1.5 LivaNova Recent Development
11.2 Physio-Control
11.2.1 Physio-Control Company Detail
11.2.2 Physio-Control Business Overview
11.2.3 Physio-Control Cardiac Rhythm Management (CRM) Introduction
11.2.4 Physio-Control Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.2.5 Physio-Control Recent Development
11.3 Schiller
11.3.1 Schiller Company Detail
11.3.2 Schiller Business Overview
11.3.3 Schiller Cardiac Rhythm Management (CRM) Introduction
11.3.4 Schiller Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.3.5 Schiller Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Cardiac Rhythm Management (CRM) Introduction
11.4.4 Medtronic Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.4.5 Medtronic Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Cardiac Rhythm Management (CRM) Introduction
11.5.4 Abbott Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Detail
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Cardiac Rhythm Management (CRM) Introduction
11.6.4 Boston Scientific Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.6.5 Boston Scientific Recent Development
11.7 Koninklijke Philips
11.7.1 Koninklijke Philips Company Detail
11.7.2 Koninklijke Philips Business Overview
11.7.3 Koninklijke Philips Cardiac Rhythm Management (CRM) Introduction
11.7.4 Koninklijke Philips Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.7.5 Koninklijke Philips Recent Development
11.8 Zoll Medical
11.8.1 Zoll Medical Company Detail
11.8.2 Zoll Medical Business Overview
11.8.3 Zoll Medical Cardiac Rhythm Management (CRM) Introduction
11.8.4 Zoll Medical Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.8.5 Zoll Medical Recent Development
11.9 Biotronik
11.9.1 Biotronik Company Detail
11.9.2 Biotronik Business Overview
11.9.3 Biotronik Cardiac Rhythm Management (CRM) Introduction
11.9.4 Biotronik Revenue in Cardiac Rhythm Management (CRM) Business (2019-2024)
11.9.5 Biotronik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
